title: [Bacterial resistance during anti-acne antibiotic therapy. How to limit the risk].
abstract: The treatment of moderate to severe acne often relies on antibiotherapy in order to eradicate as much as possible microorganisms such as Propionibacterium spp colonizing the sebaceous follicles. In recent years, bacterial resistances against specific antibiotics have emerged. Both the antibiotic and its administration modalities must be considered in order to control the risk. With regard to this conundrum, minocycline is a medication of choice among the diverse anti-acneic therapies.
authors.affiliation: Service de Dermatopathologie, Université de Liège.
authors.forename: G E
authors.initials: GE
authors.lastname: Piérard
authors.forename: J E
authors.initials: JE
authors.lastname: Arrese
authors.forename: N
authors.initials: N
authors.lastname: Claessens
authors.forename: R
authors.initials: R
authors.lastname: Greimers
authors.forename: C
authors.initials: C
authors.lastname: Piérard-Franchimont
authors.forename: J M
authors.initials: JM
authors.lastname: Naeyaert
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy* / Q000382:microbiology; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D018859:Hair Follicle / Q000382:microbiology; D006801:Humans; D008911:Minocycline / Q000627:therapeutic use; D011425:Propionibacterium acnes / Q000187:drug effects*; D012307:Risk Factors; D012627:Sebaceous Glands / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D008911:Minocycline